InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: Jelly Bean post# 83741

Tuesday, 05/26/2020 3:07:51 PM

Tuesday, May 26, 2020 3:07:51 PM

Post# of 97081
Actually, I was expecting something much stronger from the SEC filing. SEC document doesn't even accuse KB or the company of illegal insider trading or stock manipulation. It infers that the stock price went up because of the PRs. Okay, but who was trading the 100M shares? How many other websites, DT with followers were the ones pushing up the price? If there is a crime, go there.

Had to smile when they claim that investors were misled by KB stating that DECN received Pre-EUA number for its submission. What? Are you kidding. PRs continued to clearly say product in development and had to go through rigorous testing, but the SEC feels someone would misinterpret that as reason enough to Suspend Trading? hmmm not too strong of an argument, reaching in my opinion.

Most damaging statements in SEC filing are claims of past history of KB making exaggerated or false statements.

But even the segment that they put front and center needs to be read twice and is not necessarily a convincing blow:

Berman, who alone drafted the press releases on behalf of DECN, stated or suggested in interviews with staff that he:

•knew that the company had no COVID-19 test kits;
•had not seen any of DECN’s prototype COVID-19 test kits;
•had no idea how many test kits DECN could produce;
•knew that the COVID-19 test kits would require component parts that were different from DECN’s current diabetes products, which the company did not yet have and would need before any sales could be made;



Sounds like an open and shut case on first reading, hence urge for sell-off. But price holding up remarkably well. Why? Don't know but here are some possible reasons for these answers even an outsider would suggest:

1. KB is the US rep/contact for The Bio. The test kits were designed by Musho in consultation with others and all test materials and manufacturing are done in South Korea.

So when pressed over the phone in April, did he have test kits to sell, manufactured and boxed - no.

- had he seen them? No, because the "kits", not the strips, had not been printed, boxed and manufactured yet. He doesn't have them in CA. He's not a scientist. what would looking at them do for him? They will look much like the other test strips. He is communicating with the scientists and those doing the design and testing, then taking their word on whether or not it works. Lots of CEOs do that.

- he didn't know how many he could produce for varying factors at that time, including getting the materials on time, partnerships etc.

- the fact of needing materials and production being dependent on obtaining those materials were stated in PRs and/or disclosure documents (no surprise here - he had publicly stated it)

So, while the SEC filing is a punch, it remains to be seen if it is a knockout punch or a temporary knock down, from which he rises before the end of the count.

If the SEC files the documents on time, we should see the response in less than 2 weeks and possibly other news as well. The game is not over yet.